Zürcher Nachrichten - Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

EUR -
AED 4.246607
AFN 72.836971
ALL 95.988209
AMD 436.44581
ANG 2.069579
AOA 1060.176801
ARS 1608.790603
AUD 1.643499
AWG 2.083934
AZN 1.97002
BAM 1.953554
BBD 2.327913
BDT 141.823246
BGN 1.976193
BHD 0.436496
BIF 3433.722833
BMD 1.156136
BND 1.478219
BOB 7.98692
BRL 6.124098
BSD 1.155866
BTN 108.057219
BWP 15.761082
BYN 3.506783
BYR 22660.258427
BZD 2.324617
CAD 1.584894
CDF 2630.208986
CHF 0.911336
CLF 0.027173
CLP 1072.952133
CNY 7.961617
CNH 7.983279
COP 4295.63351
CRC 539.876895
CUC 1.156136
CUP 30.637594
CVE 110.816056
CZK 24.52284
DJF 205.46888
DKK 7.471717
DOP 68.212417
DZD 152.647385
EGP 60.388322
ERN 17.342035
ETB 181.687168
FJD 2.560205
FKP 0.866013
GBP 0.866414
GEL 3.138955
GGP 0.866013
GHS 12.607705
GIP 0.866013
GMD 84.980421
GNF 10147.984977
GTQ 8.853781
GYD 241.825078
HKD 9.057144
HNL 30.707411
HRK 7.532575
HTG 151.633679
HUF 393.293647
IDR 19618.465574
ILS 3.59457
IMP 0.866013
INR 108.402288
IQD 1514.537681
IRR 1521040.943935
ISK 143.812158
JEP 0.866013
JMD 181.590416
JOD 0.819746
JPY 184.071249
KES 149.839573
KGS 101.101638
KHR 4636.104298
KMF 493.670321
KPW 1040.465241
KRW 1737.72393
KWD 0.35446
KYD 0.963205
KZT 555.688646
LAK 24839.574501
LBP 103531.946431
LKR 360.563851
LRD 212.006417
LSL 19.666308
LTL 3.413768
LVL 0.699335
LYD 7.376585
MAD 10.822012
MDL 20.129116
MGA 4821.085995
MKD 61.715229
MMK 2427.622447
MNT 4127.028255
MOP 9.329732
MRU 46.396161
MUR 53.764632
MVR 17.874294
MWK 2008.207995
MXN 20.710673
MYR 4.554063
MZN 73.881379
NAD 19.458199
NGN 1567.986267
NIO 42.453736
NOK 11.059224
NPR 172.891204
NZD 1.980241
OMR 0.44452
PAB 1.155886
PEN 4.02224
PGK 4.984968
PHP 69.346754
PKR 322.797348
PLN 4.277841
PYG 7549.286912
QAR 4.213541
RON 5.094285
RSD 117.472674
RUB 96.105493
RWF 1686.80189
SAR 4.341061
SBD 9.308811
SCR 17.325632
SDG 694.837908
SEK 10.812736
SGD 1.481265
SHP 0.867401
SLE 28.412077
SLL 24243.598694
SOS 660.735749
SRD 43.340639
STD 23929.673396
STN 24.874258
SVC 10.113371
SYP 128.059734
SZL 19.458189
THB 37.961757
TJS 11.101879
TMT 4.058036
TND 3.363242
TOP 2.783697
TRY 51.227912
TTD 7.841949
TWD 36.970332
TZS 2990.534467
UAH 50.634759
UGX 4368.957522
USD 1.156136
UYU 46.576445
UZS 14099.074443
VES 525.68404
VND 30420.240803
VUV 137.62215
WST 3.172627
XAF 655.212115
XAG 0.016652
XAU 0.000253
XCD 3.124515
XCG 2.083096
XDR 0.816065
XOF 659.579533
XPF 119.331742
YER 275.858111
ZAR 19.718414
ZMK 10406.612213
ZMW 22.568343
ZWL 372.275202
  • RBGPF

    -13.5000

    69

    -19.57%

  • CMSD

    -0.1490

    22.751

    -0.65%

  • CMSC

    -0.1400

    22.71

    -0.62%

  • RYCEF

    -0.6100

    15.99

    -3.81%

  • GSK

    -0.3700

    52

    -0.71%

  • RIO

    -2.4300

    83.22

    -2.92%

  • BCC

    -1.1450

    68.715

    -1.67%

  • BCE

    0.1100

    25.84

    +0.43%

  • NGG

    -2.8100

    82.72

    -3.4%

  • VOD

    -0.0650

    14.355

    -0.45%

  • RELX

    -0.2900

    33.53

    -0.86%

  • AZN

    -4.4900

    184.44

    -2.43%

  • BTI

    -1.1550

    57.565

    -2.01%

  • JRI

    -0.1850

    11.975

    -1.54%

  • BP

    -0.8250

    45.035

    -1.83%

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.

Text size:

ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios.

"Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 study sites globally - arming sponsors with portfolio-wide operational visibility so they can anticipate trial risk, act on insights, and drive execution on the ground."

Solving the $1 million per study problem

While digital-first sites set new standards for operational speed and efficiency, much of the industry still remains offline. Only 30% of global sites currently use an eISF, leaving roughly 200,000 sites dependent on inefficient paper processes for study startup, document collection and storage, regulatory process management, monitoring and closeout.

This lack of digitization costs sponsors an estimated $1 million per study in lost productivity, rework, quality and compliance risk.

Florence is closing this digital divide through the fastest growing clinical research network of 65,000 study sites and 600+ sponsors. By digitizing 100% of operational workflows, Florence sets the standard for startup speed, operational cost reduction, and risk control.

The results are compelling:

  • Up to 70% faster last mile study startup operations compared to the average site startup time for a Top 10 global pharmaceutical sponsor.

  • $141M annual operational cost takeout by automating site readiness workflows, based on active daily users and total hours saved per year across Florence's study site network.

  • 51% increase in eTMF QA pass rates from 65% to 98.7%, due to built-in operational audits and automated compliance checks to control risk.

Shaping the Future of Study Operations

Florence is embedding AI across the study lifecycle to unlock operational data intelligence, recommend next-best actions, strengthen risk control, and improve operating efficiency.

Site Identification & Feasibility

Drawing on the industry's largest network of site intelligence, Florence enables sponsors and CROs to identify the most qualified sites by therapeutic area, geography, and performance, while AI-assisted feasibility surveys ensure faster, more accurate completion.

Study Startup

AI-enabled contracting and document exchange between eTMF and eISF automates SSU document exchange, while generative AI redlining shortens contract review cycles, compares terms in seconds, and dramatically reduces time to activation.

Remote Monitoring

AI-powered reporting surfaces early risk signals from operational audit trails and site data, providing real-time visibility and enabling proactive intervention. These insights minimize the need for on-site visits and ensure trials stay on schedule.

Together, these advancements move sponsors and CROs from manual oversight to intelligent execution across global study portfolios. Through its open API network, Florence rapidly integrates and extends its trial operation capabilities to other eClinical partner systems.

Florence AI operates at the speed of trust, ensuring every study remains fully aligned with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.

All capabilities will be available in December 2025.

Join the Movement: Research Revolution 2025

Florence will showcase its newest capabilities at Research Revolution 2025, the company's annual global event (October 26-28, 2025) bringing together sponsors, CROs, and research sites. Be part of the global revolution. Watch it live at: https://researchrevolutionsummit.com/live/

About Florence Healthcare

Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.

Contact Information

Seema Sheth-Voss
[email protected]
(888) 829-0896

SOURCE: Florence Healthcare



View the original press release on ACCESS Newswire

W.Odermatt--NZN